Literature DB >> 15613582

Neurobehavioral effects of treatment for opiate withdrawal.

M G Coyle1, A Ferguson, L Lagasse, J Liu, B Lester.   

Abstract

A partially randomised, controlled trial was performed to test the hypothesis that opiate exposed infants treated with diluted tincture of opium (DTO) and phenobarbital would have better neurobehavioral scores than infants treated with DTO alone. Compared with those treated with DTO alone (n = 15), infants treated with DTO and phenobarbital (n = 17) were more interactive, had smoother movements, were easier to handle, and less stressed. Dual treatment results in improved neurobehavioral organisation during the first three weeks of life, which may indicate a more rapid recovery from opiate withdrawal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613582      PMCID: PMC1721824          DOI: 10.1136/adc.2003.046276

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  21 in total

1.  Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.

Authors:  Linda L LaGasse; Trecia Wouldes; Elana Newman; Lynne M Smith; Rizwan Z Shah; Chris Derauf; Marilyn A Huestis; Amelia M Arria; Sheri Della Grotta; Tara Wilcox; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2010-07-06       Impact factor: 3.763

2.  Examining the joint contribution of placental NR3C1 and HSD11B2 methylation for infant neurobehavior.

Authors:  Allison A Appleton; Barry M Lester; David A Armstrong; Corina Lesseur; Carmen J Marsit
Journal:  Psychoneuroendocrinology       Date:  2014-11-10       Impact factor: 4.905

3.  NICU Network Neurobehavioral Scale profiles predict developmental outcomes in a low-risk sample.

Authors:  Heidi Sucharew; Jane C Khoury; Yingying Xu; Paul Succop; Kimberly Yolton
Journal:  Paediatr Perinat Epidemiol       Date:  2012-05-17       Impact factor: 3.980

4.  The association of prenatal exposure to intensive traffic with early preterm infant neurobehavioral development as reflected by the NICU Network Neurobehavioral Scale (NNNS).

Authors:  Xueying Zhang; Emily Spear; Chris Gennings; Paul C Curtin; Allan C Just; Jennifer B Bragg; Annemarie Stroustrup
Journal:  Environ Res       Date:  2020-01-31       Impact factor: 6.498

Review 5.  Grandchild of the NBAS: the NICU network neurobehavioral scale (NNNS): a review of the research using the NNNS.

Authors:  Ed Tronick; Barry M Lester
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2013-08

6.  Neonatal neurobehavior predicts medical and behavioral outcome.

Authors:  Jing Liu; Carla Bann; Barry Lester; Edward Tronick; Abhik Das; Linda Lagasse; Charles Bauer; Seetha Shankaran; Henrietta Bada
Journal:  Pediatrics       Date:  2009-12-07       Impact factor: 7.124

7.  Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine.

Authors:  Monica S Paz; Lynne M Smith; Linda L LaGasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2008-12-03       Impact factor: 3.763

8.  Prenatal methadone exposure and neonatal neurobehavioral functioning.

Authors:  Martha L Velez; Lauren M Jansson; Jennifer Schroeder; Erica Williams
Journal:  Pediatr Res       Date:  2009-12       Impact factor: 3.756

9.  Low-level prenatal exposure to nicotine and infant neurobehavior.

Authors:  Kimberly Yolton; Jane Khoury; Yingying Xu; Paul Succop; Bruce Lanphear; John T Bernert; Barry Lester
Journal:  Neurotoxicol Teratol       Date:  2009-07-17       Impact factor: 3.763

10.  Prenatal methamphetamine use and neonatal neurobehavioral outcome.

Authors:  Lynne M Smith; Linda L Lagasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Melissa Fallone; Jing Liu; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2007-10-03       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.